Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12652) 12652
Publication (1265) 1265
Book Chapter (112) 112
Book Review (107) 107
Conference Proceeding (30) 30
Magazine Article (16) 16
Newsletter (9) 9
Dissertation (8) 8
Book / eBook (5) 5
Web Resource (3) 3
Streaming Video (2) 2
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9808) 9808
follicular lymphoma (5228) 5228
female (4640) 4640
male (4541) 4541
index medicus (4508) 4508
middle aged (4086) 4086
oncology (3550) 3550
adult (3359) 3359
aged (3223) 3223
hematology (2950) 2950
lymphoma, follicular - pathology (2380) 2380
lymphomas (1910) 1910
non-hodgkins-lymphoma (1817) 1817
rituximab (1799) 1799
pathology (1767) 1767
lymphoma (1581) 1581
prognosis (1472) 1472
cancer (1466) 1466
lymphoma, follicular - drug therapy (1414) 1414
b-cell lymphoma (1338) 1338
aged, 80 and over (1311) 1311
lymphoma, follicular - genetics (1310) 1310
antineoplastic combined chemotherapy protocols - therapeutic use (1188) 1188
treatment outcome (1176) 1176
animals (1151) 1151
immunohistochemistry (1144) 1144
chemotherapy (1129) 1129
expression (1047) 1047
immunology (958) 958
survival (937) 937
lymphoma, follicular - diagnosis (914) 914
lymphoma, follicular - therapy (910) 910
chronic lymphocytic-leukemia (889) 889
adolescent (811) 811
antineoplastic agents - therapeutic use (775) 775
diagnosis, differential (762) 762
diagnosis (738) 738
retrospective studies (737) 737
translocation, genetic (732) 732
therapy (709) 709
research (706) 706
disease-free survival (691) 691
neoplasm staging (686) 686
lymphoma, follicular - mortality (679) 679
apoptosis (661) 661
care and treatment (656) 656
lymphoma, b-cell - pathology (636) 636
analysis (631) 631
antibodies, monoclonal - therapeutic use (622) 622
mice (601) 601
polymerase chain reaction (597) 597
hemic and lymphatic diseases (584) 584
non-hodgkin's lymphomas (581) 581
lymphoma, non-hodgkin - pathology (578) 578
cell biology (577) 577
antibodies, monoclonal, murine-derived (570) 570
lymph nodes - pathology (568) 568
medicine & public health (562) 562
lymphoma, follicular - immunology (556) 556
follow-up studies (545) 545
transplantation (539) 539
lymphoma, large b-cell, diffuse - pathology (525) 525
biopsy (521) 521
child (518) 518
young adult (515) 515
gene (513) 513
survival analysis (513) 513
combined modality therapy (510) 510
article (508) 508
lymphoma, follicular - metabolism (502) 502
leukemia (499) 499
tumors (499) 499
abridged index medicus (496) 496
disease (493) 493
survival rate (488) 488
risk factors (470) 470
anti-cd20 monoclonal-antibody (468) 468
lymphoma, b-cell - genetics (467) 467
lymphoma, non-hodgkin - drug therapy (453) 453
classification (450) 450
lymphoma, follicular (447) 447
immunophenotyping (443) 443
health aspects (438) 438
immunotherapy (434) 434
mutation (432) 432
bcl-2 (426) 426
t cells (425) 425
flow cytometry (424) 424
surgery (423) 423
recurrence (421) 421
lymphocytes (413) 413
b-lymphocytes - immunology (411) 411
gene expression (411) 411
t (411) 411
low-grade (407) 407
remission induction (407) 407
genetic aspects (403) 403
b-cells (397) 397
cyclophosphamide - administration & dosage (397) 397
medicine, research & experimental (392) 392
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11491) 11491
German (290) 290
French (237) 237
Japanese (183) 183
Spanish (133) 133
Italian (98) 98
Chinese (92) 92
Russian (90) 90
Korean (33) 33
Polish (33) 33
Czech (32) 32
Hungarian (14) 14
Portuguese (13) 13
Romanian (10) 10
Dutch (8) 8
Danish (7) 7
Turkish (6) 6
Bulgarian (4) 4
Croatian (3) 3
Norwegian (3) 3
Serbian (3) 3
Swedish (3) 3
Bosnian (2) 2
Finnish (2) 2
Slovak (2) 2
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Primary cutaneous B-cell lymphomas with large cell predominance–primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma
by Hope, Charity B and Pincus, Laura B
Seminars in Diagnostic Pathology, ISSN 0740-2570, 01/2017, Volume 34, Issue 1, pp. 85 - 98
In this review, we present clinical features and detailed histopathologic, immunologic, and molecular information regarding primary cutaneous follicle center... 
Primary cutaneous follicle center lymphoma | Intravascular large B-cell lymphoma | Primary cutaneous B-cell lymphoma | Primary cutaneous diffuse large B-cell lymphoma, leg type | TREATMENT-OF-CANCER | DIFFERENTIAL-DIAGNOSIS | PROGNOSTIC-FACTORS | EUROPEAN-AMERICAN CLASSIFICATION | BCL-2 PROTEIN EXPRESSION | WHO-EORTC CLASSIFICATION | MYCOSIS-FUNGOIDES | ADHESION MOLECULES | PATHOLOGY | CLINICAL PRESENTATION | MEDICAL LABORATORY TECHNOLOGY | CLINICOPATHOLOGICAL FEATURES | Skin Neoplasms - pathology | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Humans | Lymphoma, Follicular - diagnosis | Vascular Neoplasms - diagnosis | Leg | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphoma, Follicular - genetics | Skin Neoplasms - diagnosis | Skin Neoplasms - genetics | Vascular Neoplasms - genetics | Vascular Neoplasms - pathology | Lymphoma, Large B-Cell, Diffuse - genetics
Journal Article
Details down arrow
2. Lymphoma
by Mugnaini, Emiliano N and Ghosh, Nilanjan
Primary Care - Clinics in Office Practice, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Lymphomas may be broadly divided into non-Hodgkin (90%) and Hodgkin (10%) types. Most lymphomas (90%) are of B cell origin but can also be T cell or natural... 
Diffuse large B cell | T cell | Burkitt | Non-Hodgkin | Hodgkin | Follicular | Lymphoma | MALT | MANTLE-CELL LYMPHOMA | PLUS RITUXIMAB | BRENTUXIMAB VEDOTIN | OPEN-LABEL | CHOP CHEMOTHERAPY | PIVOTAL PHASE-II | MEDICINE, GENERAL & INTERNAL | BURKITTS-LYMPHOMA | REFRACTORY HODGKINS LYMPHOMA | RESPONSE-ADAPTED THERAPY | COMBINATION CHEMOTHERAPY | PRIMARY HEALTH CARE | Decision Making | Lymphoma - therapy | Humans | Quality of Life | Lymphoma - pathology | Antineoplastic Agents - therapeutic use | Disease Management | Primary Health Care | Index Medicus
Journal Article
Details down arrow
3. Full Text B-cell Lymphomas with Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms with Clinical and Pathologic Features Distinct from Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
by Snuderl, Matija and Kolman, Olga K and Chen, Yi-Bin and Hsu, Jessie J and Ackerman, Adam M and Cin, Paola Dal and Ferry, Judith A and Harris, Nancy Lee and Hasserjian, Robert P and Zukerberg, Lawrence R and Abramson, Jeremy S and Hochberg, Ephraim P and Lee, Hang and Lee, Alfred I and Toomey, Christiana E and Sohani, Aliyah R
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | SURGERY | MALIGNANT-LYMPHOMAS | TRANSLOCATIONS | T(14/18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | POOR-PROGNOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Lymphoma
by Bodet-Milin, C and Itti, E and Salaun, PY
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, ISSN 0928-1258, 01/2019, Volume 43, Issue 1, pp. 150 - 160
B-CELL LYMPHOMA | POSITRON-EMISSION-TOMOGRAPHY | THERAPY RESPONSE ASSESSMENT | BURDEN FOLLICULAR LYMPHOMA | PROGRESSION-FREE SURVIVAL | BONE-MARROW INVOLVEMENT | INTERIM F-18-FDG PET | NON-HODGKIN-LYMPHOMA | INTERNATIONAL HARMONIZATION PROJECT | PATHOLOGY | METABOLIC TUMOR VOLUME
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
by Tzankov, Alexandar and Meier, Cecile and Hirschmann, Petra and Went, Philip and Pileri, Stefano A and Dirnhofer, Stephan
Haematologica, ISSN 0390-6078, 02/2008, Volume 93, Issue 2, pp. 193 - 200
1 Institute of Pathology, University Hospital Basel, Switzerland; 2 Institute of Pathology, Triemli Hospital, Zurich, Switzerland; 3 Chair of Pathology and... 
Receiver operating characteristic curves | Tissue microarray | FOXP3 | Lymphoma | Treg | ACTIVATION | tissue microarray | receiver operating characteristic curves | lymphoma | PHENOTYPE | SUPPRESSION | ACT | TRANSCRIPTION FACTOR FOXP3 | RARE EXPRESSION | HEMATOLOGY | LYMPHOCYTES | Forkhead Transcription Factors - immunology | Immunohistochemistry | Age Factors | Hodgkin Disease - pathology | Cell Count | Germinal Center - immunology | Humans | Middle Aged | Male | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Microarray Analysis | Lymphoma, B-Cell - immunology | Hodgkin Disease - mortality | Adult | Female | Retrospective Studies | Lymphoma, B-Cell - mortality | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Survival Rate | Germinal Center - pathology | Disease-Free Survival | Lymphoma, Follicular - immunology | Adolescent | Lymphoma, B-Cell - pathology | Hodgkin Disease - immunology | Aged | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Conjunctival Lymphoma—An International Multicenter Retrospective Study
by Kirkegaard, Marina M and Rasmussen, Peter K and Coupland, Sarah E and Esmaeli, Bita and Finger, Paul T and Graue, Gerardo F and Grossniklaus, Hans E and Honavar, Santosh G and Khong, Jwu J and McKelvie, Penny A and Mulay, Kaustubh and Prause, Jan U and Ralfkiaer, Elisabeth and Sjö, Lene D and Toft, Peter B and Vemuganti, Geeta K and Thuro, Bradley A and Curtin, Jeremy and Heegaard, Steffen
JAMA Ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
IMPORTANCE: To date, the clinical features of the various subtypes of conjunctival lymphoma (CL) have not been previously evaluated in a large cohort.... 
CLINICAL-PRACTICE GUIDELINES | WALDEYERS RING | MANTLE CELL LYMPHOMA | LYMPHOPROLIFERATIVE DISEASE | OCULAR ADNEXA | OPHTHALMOLOGY | NON-HODGKIN-LYMPHOMA | FOLLOW-UP | FOLLICULAR LYMPHOMA | MARGINAL ZONE LYMPHOMA | FEATURES | Immunohistochemistry | Lymphoma, Follicular - therapy | Prognosis | Humans | Middle Aged | Lymphoma, B-Cell, Marginal Zone - therapy | Male | Burkitt Lymphoma - epidemiology | Incidence | Burkitt Lymphoma - pathology | Lymphoma, Follicular - epidemiology | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma - therapy | Neoplasm Invasiveness - pathology | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Databases, Factual | Burkitt Lymphoma - therapy | Lymphoma - epidemiology | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Disease-Free Survival | Conjunctival Neoplasms - epidemiology | Internationality | Lymphoma, Large B-Cell, Diffuse - epidemiology | Survival Analysis | Aged | Biopsy, Needle | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy
by Zhang, Leo and Nomie, Krystle and Zhang, Hui and Bell, Taylor and Pham, Lan and Kadri, Sabah and Segal, Jeremy and Li, Shaoying and Zhou, Shouhao and Santos, David and Richard, Shawana and Sharma, Shruti and Chen, Wendy and Oriabure, Onyekachukwu and Liu, Yang and Huang, Shengjian and Guo, Hui and Chen, Zhihong and Tao, Wenjing and Li, Carrie and Wang, Jack and Fang, Bingliang and Wang, Jacqueline and Li, Lei and Badillo, Maria and Ahmed, Makhdum and Thirumurthi, Selvi and Huang, Steven Y and Shao, Yiping and Lam, Laura and Yi, Qing and Wang, Y. Lynn and Wang, Michael
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Non‐Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
by Al‐Hamadani, Mohammed and Habermann, Thomas M and Cerhan, James R and Macon, William R and Maurer, Matthew J and Go, Ronald S
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
The World Health Organization classification of non‐Hodgkin lymphoma (NHL) was introduced in 2001. However, its incorporation into clinical practice is not... 
UNITED-STATES | REVISION | AMERICA | INFLAMMATORY-BOWEL-DISEASE | NEOPLASMS | CLASSIFICATION | T-CELL LYMPHOMA | HEMATOLOGY | WORLD-HEALTH-ORGANIZATION | EPIDEMIOLOGY | United States | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Leukemia, Hairy Cell - mortality | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Lymphoma, Mantle-Cell - mortality | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | B-Lymphocytes - pathology | T-Lymphocytes - pathology | Leukemia, Hairy Cell - pathology | Databases, Factual | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Terminology as Topic | Burkitt Lymphoma - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Lymphoma, Large-Cell, Anaplastic - mortality | Leukemia, Hairy Cell - diagnosis | Lymphoma, B-Cell, Marginal Zone - diagnosis | Survival Analysis | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Lymphoma, Large-Cell, Anaplastic - pathology | Longitudinal Studies | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Databases | Non-Hodgkin's lymphomas | Native Americans | T cells | Analysis | Leukemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Composite lymphoma of follicular B-cell and peripheral T-cell types with distinct zone distribution in a 75-year-old male patient: a case study
by Tanaka, John and Su, Pu and Luedke, Catherine and Jug, Rachel and Yang, Lian-He and Deak, Kristen and Rapisardo, Sarah and Zhang, Yang and Delos Angeles, Marc and Xie, Yi and Wang, Endi
Human Pathology, ISSN 0046-8177, 06/2018, Volume 76, pp. 110 - 116
Composite lymphoma of T-/B-cell type is rare, and follicular lymphoma composite with peripheral T-cell lymphoma (PTCL) has not previously been reported. We... 
Zone distribution | Follicular lymphoma | Composite lymphoma | In situ | T-cell lymphoma | B-cell lymphoma | PATHOLOGY | CLINICOPATHOLOGICAL ANALYSIS | Immunohistochemistry | Composite Lymphoma - therapy | Lymphoma, Follicular - therapy | Trisomy | Humans | Lymphoma, B-Cell - therapy | Male | Tetrasomy | Lymphoma, B-Cell - genetics | Genes, Immunoglobulin Heavy Chain | Composite Lymphoma - immunology | Lymphoma, Follicular - genetics | Lymphoma, B-Cell - immunology | Antigens, CD20 - analysis | Biomarkers, Tumor - analysis | Lymphoma, Follicular - pathology | Lymphoma, T-Cell, Peripheral - genetics | Gene Fusion | In Situ Hybridization, Fluorescence | Gene Amplification | Lymphoma, Follicular - immunology | Composite Lymphoma - pathology | Lymphoma, T-Cell, Peripheral - pathology | Lymphoma, B-Cell - pathology | Aged | Biomarkers, Tumor - genetics | Lymphoma, T-Cell, Peripheral - therapy | Proto-Oncogene Proteins c-bcl-2 - genetics | Composite Lymphoma - genetics | Lymphoma, T-Cell, Peripheral - immunology | Case studies | Medical research | Analysis | Cytogenetics | Medicine, Experimental | Non-Hodgkin's lymphomas | T cells | Antigens | Lymphatic system | Chemotherapy | Lymphocytes | Lymphomas | Tumors | Stains & staining
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Transformation of follicular lymphoma
by Lossos, Izidore S and Gascoyne, Randy D
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2011, Volume 24, Issue 2, pp. 147 - 163
Histological transformation of follicular lymphoma (FL) to a more aggressive non-Hodgkin’s lymphomas is a pivotal event in the natural history of FL and is... 
Hematology, Oncology and Palliative Medicine | DLBCL | follicular lymphoma | transformation | MYC | transplantation | HISTOLOGIC TRANSFORMATION | TUMOR PROGRESSION | HIGHER-GRADE TRANSFORMATION | CLINICAL-FEATURES | B-CELL LYMPHOMA | DNA COPY NUMBER | BONE-MARROW TRANSPLANTATION | HIGH-DOSE THERAPY | REFRACTORY LOW-GRADE | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | Lymphoma, Follicular - therapy | Prognosis | Humans | Salvage Therapy | Transplantation, Autologous | Lymphoma, Large B-Cell, Diffuse - etiology | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Stem Cell Transplantation | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma, Follicular - genetics | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Follicular - complications | Burkitt Lymphoma - therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Biomarkers, Tumor - analysis | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Burkitt Lymphoma - etiology | Disease Progression | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Biopsy | Chromosome Aberrations | Mutation | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Biomarkers, Tumor - biosynthesis | Research | Non-Hodgkin's lymphomas | Oncology, Experimental | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: An analysis of clinical presentation and outcome in 144 patients
by Heilgeist, Andreas and McClanahan, Fabienne and Ho, Anthony D and Witzens-Harig, Mathias
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 1, pp. 99 - 106
BACKGROUND: In marginal zone lymphoma (MZL), clinical and follow-up data on large cohorts of patients are difficult to obtain. The objective of this... 
treatment | response | survival | extranodal | Follicular Lymphoma International Prognostic Index | mucosa-associated lymphoid tissue | nodal | mucosa associated lymphoid tissue | prognosis | splenic | marginal zone lymphoma | TISSUE LYMPHOMA | COMBINATION | FEATURES | B-CELL LYMPHOMA | THERAPY | ONCOLOGY | RITUXIMAB | Severity of Illness Index | Predictive Value of Tests | Lymphoma, Follicular - therapy | Prognosis | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Male | Survival Rate | Treatment Outcome | Lymphoma, B-Cell, Marginal Zone - diagnosis | Aged, 80 and over | Adult | Female | Aged | Usage | Periodic health examinations | Analysis | Physical diagnosis | Lymphomas | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Non-Hodgkin lymphoma
by Shankland, Kate R, Dr and Armitage, James O, Prof and Hancock, Barry W, Prof
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9844, pp. 848 - 857
Summary Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | POSITRON-EMISSION-TOMOGRAPHY | ANTI-CD20 MONOCLONAL-ANTIBODY | PROSPECTIVE RANDOMIZED-TRIAL | ADVANCED FOLLICULAR LYMPHOMA | TERM-FOLLOW-UP | CHRONIC LYMPHOCYTIC-LEUKEMIA | DETUDE-DES-LYMPHOMES | STAGE-I | PERIPHERAL T-CELL | Prognosis | Humans | Antineoplastic Agents - therapeutic use | Lymphoma, Non-Hodgkin - epidemiology | Neoplasm Staging | Lymphoma, Non-Hodgkin - classification | Lymphoma, Non-Hodgkin - diagnosis | Lymphoma, Non-Hodgkin - drug therapy | Non-Hodgkin's lymphomas | Transplants & implants | Lymphocytes | Herpes viruses | Classification | Lymphomas | Infections | Kinases | Autoimmune diseases | DNA repair | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Transformation of small B-cell lymphoma into large cell CD30+, CD4+, epstein-barr virus-negative lymphoma
by Shaver, Aaron C and Shaver, Aaron C and Ma, Ly and Ma, Ly and Vnencak-Jones, Cindy and Schwarting, Roland S and Fasig, Kristina J and Kim, Annette S
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 2014, Volume 138, Issue 8, pp. 1101 - 1105
We report here 2 separate cases in which patients with known low-grade B-cell lymphomas presented with transformed lesions that were CD30(+), CD4(+),... 
MEDICINE, RESEARCH & EXPERIMENTAL | CD20 EXPRESSION | POLYMERASE-CHAIN-REACTION | HODGKINS-LYMPHOMA | GENE REARRANGEMENTS | FOLLICULAR LYMPHOMA | MEDICAL LABORATORY TECHNOLOGY | PATHOLOGY | CLONAL IMMUNOGLOBULIN | Lymphoma, Follicular - metabolism | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Proteins - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Lymphoma, Follicular - genetics | Lymphoma, Large-Cell, Anaplastic - diagnosis | Neoplasm Grading | Female | Gene Rearrangement, B-Lymphocyte | Lymphoma, Large-Cell, Anaplastic - metabolism | Lymphoma, Large-Cell, Anaplastic - genetics | Biomarkers - metabolism | Diagnosis, Differential | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Ki-1 Antigen - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Lymphoma, Large B-Cell, Diffuse - diagnosis | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Biopsy | Cell Transformation, Neoplastic | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Lymphoma, Large-Cell, Anaplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | CD4 Antigens - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text A Reappraisal of the Diagnostic and Therapeutic Management of Uncommon Histologies of Primary Ocular Adnexal Lymphoma
by Ponzoni, Maurilio and Govi, Silvia and Licata, Giada and Mappa, Silvia and Giordano Resti, Antonio and Politi, Letterio S and Spagnuolo, Lorenzo and Di Cairano, Eliana Sara and Doglioni, Claudio and Ferreri, Andrés J. M
The Oncologist, ISSN 1083-7159, 07/2013, Volume 18, Issue 7, pp. 876 - 884
Lymphoma is the most common malignancy arising in the ocular adnexa, which includes conjunctiva, lachrymal gland, lachrymal sac, eyelids, orbit soft tissue,... 
Diffuse large B‐cell lymphoma | Follicular lymphoma | Ocular adnexal lymphoma | Mantle cell lymphoma | T‐cell lymphoma | T-cell lymphoma | Diffuse large B-cell lymphoma | MARGINAL ZONE | MALT-LYMPHOMA | GASTROINTESTINAL INVOLVEMENT | ORBITAL LYMPHOMA | INTRAOCULAR LYMPHOMA | T-CELL | HEALTH-ORGANIZATION CLASSIFICATION | B-CELL LYMPHOMA | ONCOLOGY | LYMPHOPROLIFERATIVE DISEASE | NON-HODGKINS-LYMPHOMA | Adnexal Diseases - therapy | Prognosis | Eye Neoplasms - genetics | Humans | Eye Neoplasms - pathology | Lymphoma - genetics | Eye Neoplasms - therapy | Adnexal Diseases - genetics | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin - pathology | Lymphoma - therapy | Adnexal Diseases - pathology | Lymphoma, Non-Hodgkin - therapy | Biomarkers, Tumor - metabolism | Female | Lymphoma - pathology | Lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights